Quick Takeaways
- scPharmaceuticals Inc. has 12 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 12 Insiders of scPharmaceuticals Inc.
- Location
- Burlington, MA
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 03 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
scPharmaceuticals Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| 5AM Partners IV, LLC | 10%+ Owner | $17,475,704 | Mixed | 06 Oct 2022 | ||
| ORBIMED ADVISORS LLC | 10%+ Owner | $1,011,432 | Filing P/S | 13 Aug 2024 | ||
| Jack A. Khattar | Director | $0 | Mixed | 07 Oct 2025 | ||
| Leonard D. Schaeffer | Director | $0 | Mixed | 07 Oct 2025 | ||
| Rachael Nokes | CFO and Treasurer | $0 | Mixed | 07 Oct 2025 | ||
| John H. Tucker | President and CEO, Director | $0 | Mixed | 07 Oct 2025 | ||
| Sara Bonstein | Director | Mixed | 07 Oct 2025 | |||
| Mette Kirstine Agger | Director | Mixed | 07 Oct 2025 | |||
| Minnie Baylor-Henry | Director | Mixed | 07 Oct 2025 | |||
| Klaus R. Dr Veitinger | Director | Mixed | 07 Oct 2025 | |||
| Frederick M. Hudson | Director | Mixed | 07 Oct 2025 | |||
| William Tober Abraham | Director | Mixed | 07 Oct 2025 |
Top shareholders of scPharmaceuticals Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| 5AM Partners IV, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,734,852
|
$17,475,704 | — | 06 Oct 2022 | |
| KING LUTHER CAPITAL MANAGEMENT CORP |
13D/G
|
Luther King Capital Management Corporation |
4%
|
2,128,391
|
$11,982,841 | -$8,674,586 | 30 Sep 2025 | |
| GLAZER CAPITAL, LLC |
13D/G
|
— |
4.6%
|
2,474,820
|
$11,829,640 | $0 | 02 Sep 2025 | |
| ORBIMED ADVISORS LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
252,858
|
$1,011,432 | — | 13 Aug 2024 |
Recent Insider Transactions by Companies or Individuals for scPharmaceuticals Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Leonard D. Schaeffer | SCPH | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -43,104 | 0 | 07 Oct 2025 | Held by Schaeffer Holdings LLC | ||
| Leonard D. Schaeffer | SCPH | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -68,796 | 0 | 07 Oct 2025 | Direct | ||
| Leonard D. Schaeffer | SCPH | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -66,050 | 0 | 07 Oct 2025 | Direct | ||
| Klaus R. Dr Veitinger | SCPH | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -72,174 | 0 | 07 Oct 2025 | Direct | ||
| William Tober Abraham | SCPH | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -66,050 | 0 | 07 Oct 2025 | Direct | ||
| Minnie Baylor-Henry | SCPH | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -84,422 | 0 | 07 Oct 2025 | Direct | ||
| Frederick M. Hudson | SCPH | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -72,174 | 0 | 07 Oct 2025 | Direct | ||
| Rachael Nokes | SCPH | Common Stock | Disposed to Issuer | -100% | -125,675 | 0 | 07 Oct 2025 | Direct | ||
| Rachael Nokes | SCPH | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -19.5% | -30,386 | 125,675 | 07 Oct 2025 | Direct | ||
| Rachael Nokes | SCPH | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -207,646 | 0 | 07 Oct 2025 | Direct | ||
| John H. Tucker | SCPH | Common Stock | Disposed to Issuer | -100% | -318,502 | 0 | 07 Oct 2025 | Direct | ||
| John H. Tucker | SCPH | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -27.8% | -122,345 | 318,502 | 07 Oct 2025 | Direct | ||
| John H. Tucker | SCPH | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -1,130,174 | 0 | 07 Oct 2025 | Direct | ||
| Mette Kirstine Agger | SCPH | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -49,750 | 0 | 07 Oct 2025 | Direct | ||
| Sara Bonstein | SCPH | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -66,050 | 0 | 07 Oct 2025 | Direct | ||
| Jack A. Khattar | SCPH | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -5,000 | 0 | 07 Oct 2025 | Direct | ||
| Jack A. Khattar | SCPH | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -72,174 | 0 | 07 Oct 2025 | Direct | ||
| Mette Kirstine Agger | SCPH | Stock Option (Right to Buy) | Award | 30,000 | 30,000 | 03 Jun 2025 | Direct | |||
| Minnie Baylor-Henry | SCPH | Stock Option (Right to Buy) | Award | 30,000 | 30,000 | 03 Jun 2025 | Direct | |||
| Sara Bonstein | SCPH | Stock Option (Right to Buy) | Award | 30,000 | 30,000 | 03 Jun 2025 | Direct | |||
| Frederick M. Hudson | SCPH | Stock Option (Right to Buy) | Award | 30,000 | 30,000 | 03 Jun 2025 | Direct | |||
| Jack A. Khattar | SCPH | Stock Option (Right to Buy) | Award | 30,000 | 30,000 | 03 Jun 2025 | Direct | |||
| Klaus R. Dr Veitinger | SCPH | Stock Option (Right to Buy) | Award | 30,000 | 30,000 | 03 Jun 2025 | Direct | |||
| William Tober Abraham | SCPH | Stock Option (Right to Buy) | Award | 30,000 | 30,000 | 03 Jun 2025 | Direct | |||
| Leonard D. Schaeffer | SCPH | Stock Option (Right to Buy) | Award | 30,000 | 30,000 | 03 Jun 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.